DC Field | Value | Language |
---|---|---|
dc.contributor.author | H Jo | - |
dc.contributor.author | M Choi | - |
dc.contributor.author | A S Kumar | - |
dc.contributor.author | Y Jung | - |
dc.contributor.author | S Kim | - |
dc.contributor.author | Jieun Yun | - |
dc.contributor.author | Jong Soon Kang | - |
dc.contributor.author | Y Kim | - |
dc.contributor.author | S B Han | - |
dc.contributor.author | J K Jung | - |
dc.contributor.author | J Cho | - |
dc.contributor.author | K Lee | - |
dc.contributor.author | J H Kwak | - |
dc.contributor.author | H Lee | - |
dc.date.accessioned | 2017-04-19T10:20:17Z | - |
dc.date.available | 2017-04-19T10:20:17Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 1948-5875 | - |
dc.identifier.uri | 10.1021/acsmedchemlett.6b00004 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/13229 | - |
dc.description.abstract | 1,2,3,4-Tetrahydroquinolines have been identified as the most potent inhibitors of LPS-induced NF-κB transcriptional activity. To discover new molecules of this class with excellent activities, we designed and synthesized a series of novel derivatives of 1,2,3,4-tetrahydroquinolines (4a-g, 5a-h, 6a-h, and 7a-h) and bioevaluated their in vitro activity against human cancer cell lines (NCI-H23, ACHN, MDA-MB-231, PC-3, NUGC-3, and HCT 15). Among all synthesized scaffolds, 6g exhibited the most potent inhibition (53 times that of a reference compound) of LPS-induced NF-κB transcriptional activity and the most potent cytotoxicity against all evaluated human cancer cell lines. | - |
dc.publisher | Amer Chem Soc | - |
dc.title | Development of novel 1,2,3,4-tetrahydroquinoline scaffolds as potent NF-κB inhibitors and cytotoxic agents | - |
dc.title.alternative | Development of novel 1,2,3,4-tetrahydroquinoline scaffolds as potent NF-κB inhibitors and cytotoxic agents | - |
dc.type | Article | - |
dc.citation.title | ACS Medicinal Chemistry Letters | - |
dc.citation.number | 4 | - |
dc.citation.endPage | 390 | - |
dc.citation.startPage | 385 | - |
dc.citation.volume | 7 | - |
dc.contributor.affiliatedAuthor | Jieun Yun | - |
dc.contributor.affiliatedAuthor | Jong Soon Kang | - |
dc.contributor.alternativeName | 조혜주 | - |
dc.contributor.alternativeName | 최민호 | - |
dc.contributor.alternativeName | Kumar | - |
dc.contributor.alternativeName | 정영은 | - |
dc.contributor.alternativeName | 김상은 | - |
dc.contributor.alternativeName | 윤지은 | - |
dc.contributor.alternativeName | 강종순 | - |
dc.contributor.alternativeName | 김영수 | - |
dc.contributor.alternativeName | 한상배 | - |
dc.contributor.alternativeName | 정재경 | - |
dc.contributor.alternativeName | 조정숙 | - |
dc.contributor.alternativeName | 이기호 | - |
dc.contributor.alternativeName | 곽재환 | - |
dc.contributor.alternativeName | 이희순 | - |
dc.identifier.bibliographicCitation | ACS Medicinal Chemistry Letters, vol. 7, no. 4, pp. 385-390 | - |
dc.identifier.doi | 10.1021/acsmedchemlett.6b00004 | - |
dc.subject.keyword | 1,2,3,4-Tetrahydroquinolines | - |
dc.subject.keyword | human cancer cell lines | - |
dc.subject.keyword | in vitro cytotoxicity | - |
dc.subject.keyword | NF-κB inactivation | - |
dc.subject.local | 1,2,3,4-Tetrahydroquinolines | - |
dc.subject.local | Human cancer cell line | - |
dc.subject.local | human cancer cell lines | - |
dc.subject.local | Human cancer cell lines | - |
dc.subject.local | in vitro cytotoxicity | - |
dc.subject.local | NF-κB inactivation | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.